Enoxacin

Developed for: amyotrophic lateral sclerosis
Investigated by: Apotex Inc. · McGill University · Weizmann Institute of Science

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Approved	US (FDA)	PENETREX	—	1991-12-31	fda.gov ↗

today

US approved 1991

NCT04840823 · Ph 1/2

1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT04840823	Mar 2021 → Nov 2023	amyotrophic lateral sclerosis	McGill University	Completed	No outcome recorded

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 0	NCT02099240 Comparator	Mar 2014 → Nov 2018	osteomyelitis	University of Louisville	Terminated	No outcome recorded

Every value below carries the sentence it was read from. 3 sources stand behind the page.

Field	Value	Cited text
Known as	Enoxacin	“Enoxacin” NCT02099240 ↗ 1 NCT04840823 ↗
Known as	AT-2266	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Known as	CI-919	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Known as	Comprecin	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Known as	Enoxacine	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Known as	Enoxacino	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Known as	Flumark	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Known as	NSC-629661	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Known as	NSC-758416	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Known as	PD 107779	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Known as	Penetrex	ChEMBL registry synonym — accepted as the source's own label CHEMBL826 ↗
Modality	Small molecule	— CHEMBL826 ↗
Route	Oral	“Oral 200mg tablet” NCT04840823 ↗